Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

39.95
-0.1500-0.37%
Post-market: 39.950.00000.00%19:30 EDT
Volume:587.80K
Turnover:23.31M
Market Cap:3.85B
PE:-20.42
High:40.20
Open:39.85
Low:38.90
Close:40.10
52wk High:42.68
52wk Low:23.23
Shares:96.27M
Float Shares:94.37M
Volume Ratio:0.74
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9561
EPS(LYR):-1.2849
ROE:-16.22%
ROA:-11.54%
PB:3.21
PE(LYR):-31.09

Loading ...

IDEAYA Biosciences Is Maintained at Buy by Guggenheim

Dow Jones
·
Apr 14

Ideaya Biosciences price target raised to $54 from $50 at Guggenheim

TIPRANKS
·
Apr 14

IDEAYA Biosciences Inc : Truist Securities Raises Target Price to $65 From $60

THOMSON REUTERS
·
Apr 14

IDEAYA Biosciences, Inc. : Wells Fargo Raises Target Price to $48 From $44

THOMSON REUTERS
·
Apr 14

U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines

Reuters
·
Apr 14

IDEAYA Biosciences Inc : Leerink Partners Raises Target Price to $37 From $34

THOMSON REUTERS
·
Apr 14

IDEAYA Biosciences Inc : Guggenheim Raises Target Price to $54 From $50

THOMSON REUTERS
·
Apr 14

Ideaya Biosciences price target raised to $65 from $60 at Truist

TIPRANKS
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune

Reuters
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma

Reuters
·
Apr 13

IDEAYA Biosciences Up Over 17%, on Pace for Largest Percent Increase Since April 2023 -- Data Talk

Dow Jones
·
Apr 13

Wedbush Adjusts Price Target on IDEAYA Biosciences to $58 From $52, Maintains Outperform Rating

MT Newswires Live
·
Apr 13

Ideaya Biosciences rises 22.8%

TIPRANKS
·
Apr 13

IDEAYA Biosciences Shares Rise 13% After Co's Eye Cancer Drug Combo Improves Survival in Trial

THOMSON REUTERS
·
Apr 13

Ideaya Biosciences Stock Jumps 16% on Eye Cancer Therapy Trial Results

Dow Jones
·
Apr 13

IDEAYA Eye Cancer Trial Data Beats Standard Therapy, Stock Soars

Benzinga_recent_news
·
Apr 13

Top Premarket Gainers

MT Newswires Live
·
Apr 13

Stock Track | IDEAYA Biosciences Soars 31.15% in Pre-market on Positive Phase 2/3 Trial Results for Eye Cancer Drug

Stock Track
·
Apr 13

Ideaya Biosciences Shares Jump on Trial Results

Dow Jones
·
Apr 13

BUZZ-IDEAYA Biosciences surges after eye cancer drug combo improves survival in trial

Reuters
·
Apr 13